The NIAMS-ASBMR Scientific Meeting, Bone Quality: What Is It and Can We Measure It?, was held May 2-3, 2005, at the Hyatt Regency Bethesda in Bethesda, Maryland, USA.

Organizing Committee

Gayle Lester, Ph.D., Committee Chair, Musculoskeletal Diseases Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, USA
Mary Bouxsein, Ph.D., Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA
Pierre Delmas, M.D., Ph.D., INSERM, Lyon, France
Steven Goldstein, Ph.D., Department of Orthopedic Surgery, University of Michigan Orthopedic Research Labs, Ann Arbor, MI, USA 
Theresa Kehoe, M.D., Division of Metabolic and Endocrine Drug Products, CDER, FDA, Rockville, MD, USA
Joan McGowan, Ph.D., Musculoskeletal Diseases Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, USA  
Robert R. Recker, M.D., Creighton University Osteoporosis Research Center, Omaha, NE, USA 

Meeting Program

Osteoporotic fractures occur because of a failure of bone to resist loading. "Bone Quality" is an ill-defined term used to describe the diverse factors influencing skeletal health and fracture risk that go beyond bone mineral density (BMD) measurement. Although BMD measurement is among the most useful clinical tools for diagnosing osteoporosis, its limitations are apparent. This makes bone quality and skeletal fragility among the hottest topics for basic scientists, clinical investigators and clinicians.

This two-day scientific meeting was aimed at:

Media and Press Room Activities